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Abstract A clear cell sarcoma, arising primarily in the
ileum of a 35-year-old man, is reported. Histologically, the
neoplasm infiltrated the full thickness of the intestinal wall.
It consisted of strands and sheets of round to spindle-
shaped cells with clear to eosinophilic cytoplasm, vesic-
ular nuclei and prominent nucleoli. Vascular invasion was
present at diagnosis. Tumour cells expressed S-100 protein,
melan-A and tyrosinase. They were negative for HMB45,
CD117, cytokeratins, epithelial membrane antigen, smooth
muscle actin, desmin, CD31, CD34, chromogranin and syn-
aptophysin. Reverse transcription–polymerase chain reac-
tion analysis performed on paraffin-embedded tissue
showed EWS–ATF1 fusion transcripts representative of
the t(12;22) (q13;q12) clear cell sarcoma reciprocal trans-
location. The patient, who developed liver metastases 2
months after diagnosis, died of disease at 15 months. This
case demonstrates that the gastrointestinal tract is a poten-
tial site for primary clear cell sarcoma of soft tissues, and,
furthermore, that cytogenetics and/or molecular techniques
play a central role in the diagnosis.
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Introduction
Clear cell sarcoma (also known as malignant melanoma of
soft tissues) is a rare tumour that typically occurs in the
tendon sheaths and aponeuroses of distal extremities of
adolescents and young adults [3, 6, 10, 11]. Involvement
of the gastrointestinal tract is exceedingly rare and, fre-
quently, a source of diagnostic problems. Six cases of di-
gestive tract clear cell sarcoma were heretofore reported in
the literature, most of them very recently [1, 4, 5, 7, 13, 15],
including one in the ileum [4]. A second ileal case is de-
scribed below. It occurred in a 35-year-old man and caused
the death of the patient 15 months after diagnosis.
Clinical history
A 35-year-old, HIV-negative man without any previous
significant medical history was admitted in March 2003
for a 15-kg weight loss over a few months and symptoms
of intestinal obstruction (i.e. colic pain, vomiting) without
fever. CT scans showed a segmental thickening of the
ileum, situated 80 cm above the ileo–caecal valve. Pre-
operative diagnoses included Meckel diverticulum, polyps
and a malignant neoplasm. At laparotomy, a single circum-
ferential, stenotic lesion of the ileum was found. There was
neither other detectable tumour in the abdominal cavity nor
any liver metastases. The ileal mass was resected along
with 20 cm of ileum and one regional mesenteric lymph
node. A pathologic diagnosis of unclassified non-epithelial
malignant neoplasm was rendered. The mesenteric lymph
node was devoid of tumour deposits, but the ascitic fluid,
sampled at the time of surgery, contained clusters of ma-
lignant cells. A lymphoma, a GIST, a neuroendocrine neo-
plasm were excluded on the basis of immunohistochemical
results. A melanoma (primary or metastatic) was strongly
suspected owing to tumour cell reactivity for S-100 protein.
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Careful examination of the patient, including extensive ex-
amination of skin, eyes, nasosinusal cavities, throat, testes
and soft tissues failed to detect any other potential primary
tumour. The metastatic work-up was negative, as was the
PET scan. A colonoscopy showed several polyps in the
ascending and sigmoid colon, which turned out to be ad-
enomatous polyps with low-grade dysplasia at microscopic
examination.
Two months post-operatively, several metastases were
detected in the liver, along with multiple peritoneal im-
plants and amalignant ascitis. The tumour regressed dramat-
ically after six courses of a platinum-based chemotherapy,
but a second look, performed in November 2003, showed
that the malignant process extended microscopically to the
whole peritoneal subserosa and to the omentum. Lymph
node and liver biopsy specimens, taken during the second
surgical procedure, were tumour-free. From then on, and
despite various treatments, the tumour gradually progressed
in the abdomen, leading to several episodes of intestinal
obstruction. Patient’s death occurred 15 months after dis-
ease onset, as a result of Candida albicans septicemia. No
autopsy was performed.
Materials and methods
Tumour samples were fixed in 4% buffered formalin, em-
bedded in paraffin and stained with hematoxylin and eosin
and Fontana–Masson stains. Additional sections were stud-
ied with the following antibodies: S-100 protein (Dako-
patts, Glostrup, Denmark, pre-diluted), melan-A (Dako,
diluted 1:50), HMB45 (Dako, diluted 1:50), tyrosinase
(Ludwig Institute, Lausanne, Switzerland, diluted 1:50, gift
from Dr. D. Rimoldi), cytokeratins (clone C-11, diluted
1:40 and clone AE1/AE3, diluted 1:200, Novocastra Lab-
oratories Inc., Newcastle upon Tyne, UK), CD31 (Dako,
diluted 1:40), CD34 (Immunotech Beckam Coulter, Inc.,
Fullerton, CA, USA, diluted 1:160), CD45 (Dako, diluted
1:50), CD3 (Novocastra, pre-diluted), CD20 (clone L26,
Dako, pre-diluted), CD56 (clone 1B6, Novocastra, diluted
1:50), smooth muscle actin (clone 1A4, Sigma Aldrich,
St Louis, MI, USA, diluted 1:20,000), myeloperoxidase
(Dako, diluted 1:2,000), synaptophysin (Dako, diluted
1:25), chromogranin-A (Dako, diluted 1:1,000), somato-
statin (Bachem Peninsula Laboratories, Inc., San Carlos,
CA, USA, diluted 1:800), serotonin (clone 5HT-H209,
Dako, diluted 1:50) and CD117 (c-kit, Dako, polyclonal
diluted 1:200). Immunostaining was performed according
to the avidin biotin complex (ABC) method. Tissue sec-
tions were submitted to microwave oven heating prior to
staining, except for CD117 staining. All steps were per-
formed at room temperature, and diaminobenzidine was
used as chromogen. Appropriate positive and negative con-
trols were employed throughout.
Reverse transcription–polymerase chain reaction (RT-
PCR) was used to detect the presence of EWS–ATF1
transcripts in paraffin-embedded tumour samples. RNA ex-
traction and RT-PCR reaction were performed as previous-
ly described [9]. Briefly, PCR amplification was performed
in duplicate using a 96-well plate (Applied Biosystems,
Foster City, CA, USA) with a 50 μl final reaction mixture
containing 300 nM each primer; 200 nM probe ATF1 or
50 nM probe beta2-microglobulin; 200 μM of an equal
concentration of dATP, dCTP, dGTP, dTTP, dUTP; MgCl2
4 mM; 1.25 U Taq polymerase and 0.25 U Amperase UNG
in a 1X Real-Time PCR Buffer containing a passive ref-
erence (Rox fluorochrome). Thermal cycling conditions
were 2 min at 50°C for amperase activation, 10 min at 95°C
for Taq polymerase activation, then 50 cycles of two PCR
steps consisting of 15 s at 95°C and 60°C for 1 min. All
reactions were performed in the ABI Prism 5700 Sequence
Detection System (Applied Biosystems).
Primers and probe sequences were chosen with Primer
Express software (Applied Biosystems). Primers were pur-
chased from Eurobio (Les Ulis, France) and probes and
QPCR Core kit containing Real-Time PCR Buffer, dNTP,
MgCl2, amperase UNG and Taq polymerase were pur-
chased from Eurogentec (Herstal, Belgium). Probes and
primer sequences were as follows: forward primer EWS,
5′-CAT GAG CAG AGG TGG GCG-3′; reverse primer
ATF1, 5′-CCC CGT GTATCT TCA GAA GATAAG TC-
3′; probe ATF1, 5′-6-FAM-AGG AGG ACG CGG TGG
AAT GGG-TAMRA-3′; forward primer beta2-microglob-
ulin, 5′-TGA CTT TGT CAC AGC CCA AGA TA-3′;
reverse primer beta 2-microglobulin, 5′-AAT CCA AAT
GCG GCA TCT TC-3′; probe beta 2-microglobulin, 5′-6-
FAM-TGA TGC TGC TTA CAT GTC TCG ATC CCA-
TAMRA-3′.
Results
A 20-cm segment of ileum was resected, centered by a
well-defined firm, circumferential mass, measuring 1.8 cm
in maximal diameter. Cut section showed a whitish neo-
plasm that ulcerated the overlying mucosa and infiltrated
the whole thickness of the intestinal wall, extending into
the subserosa (Fig. 1.). The tumour cells, arranged in sheets
and nests separated by fibrous septa of varying thickness,
were polygonal, with a clear to eosinophilic cytoplasm.
Tumour cell nuclei were oval, often vesicular with a single
central prominent nucleolus (Fig. 2.). Neither multinucle-
ate giant cells nor melanin pigment were observed. Mitoses
were numerous (up to 32 mitoses per ten high-power fields;
one high-power field, 0.174 mm2). There was no necrosis,
but vascular invasion was present. The mesenteric lymph
node sampled was devoid of metastatic deposits. The peri-
toneal and omental biopsies taken in November 2003
showed the same neoplastic proliferation, although tumour
cells were very scarce, embedded in an abundant collag-
enous matrix. These tumour cells could easily be over-
looked in some samples.
Immunohistochemically, the tumour cells were diffusely
positive for S-100 protein (Fig. 3.) and, focally, for ty-
rosinase and melan-A. They were negative for HMB45,
keratins, EMA, smooth muscle actin, desmin, chromogra-
nin-A, synaptophysin, CD117, CD31, CD34, CD45, CD20,
CD3 and myeloperoxidase. Ultrastructurally, the tumour
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cells showed rounded to oval nuclei with smooth or
indented contours, open chromatin and one or two prom-
inent nucleoli. The cytoplasm was moderately abundant
and contained few organelles as well as immature mela-
nosomes. EWS–ATF1 fusion transcripts representative of
the t(12;22) (q13;q12) clear cell sarcoma translocation were
detected using real-time RT-PCR (Fig. 4.). The fusion oc-
curred between the exon 8 of EWS gene and the exon 4 of
the ATF-1 gene. SYT-SSX1/2 fusion transcripts, represen-
tative of the t(X;18) synovial sarcoma translocation, were
not detected.
Discussion
Described in 1965 by FM Enzinger [6], clear cell sarcoma
of tendons and aponeuroses is a peculiar type of sarcoma
which shows features of melanocytic differentiation. Clin-
ically, it presents as a slow-growing tumour (median size,
2–5 cm) that mainly affects young adults (20–40 years).
These tumours may be present for years before coming to
clinical attention. The distal extremities, particularly the
feet, ankles, knees, wrists and hands are the most common
sites of tumour development [3, 6, 10, 11]. The lesions are
almost always deep seated and intimately associated with
tendons, aponeuroses and fascia.
Clear cell sarcoma is infrequent outside the limbs. Here-
tofore, six cases of clear cell sarcoma of the digestive tract
have been reported [1, 4, 5, 7, 13, 15]. The salient clin-
icopathologic features of those cases, and the case under
discussion, are summarized in Table 1. Males seem to be
predominantly affected, in contrast to soft tissue lesions,
which are divided equally between the sexes. Median age is
37 years (mean, 40 years), and median tumour size is 4 cm.
Clear cell sarcoma of soft tissue has a poor prognosis, de-
spite various treatment regimens [3, 6, 10, 11]. The tumour
tends to metastasize to lungs but also to regional lymph
nodes and bone. The 5-year survival rate is about 50–60%.
Long term follow-up is mandatory because metastases can
develop late in the course of the disease (10 years or more
after diagnosis). Of the seven patients with a clear cell
sarcoma of the gastrointestinal tract, two had metastatic
disease at the time of diagnosis [13, 15], and an additional
four developed liver metastases 2 (current case) to 24 [4]
months post-operatively. Only two patients were disease-
free at last follow-up, 11 [1] and 18 [5] months after
diagnosis. Follow-up of patients 4 and 6 of Table 1 have
been updated recently (see Acknowledgements).
In the digestive tract, clear cell sarcoma has the same
histology and immunoprofile as in the soft tissues. The tu-
mour presents as bundles or nests of pale staining to eo-
sinophilic spindle cells separated by dense fibrous tissue
septa. Tumour cells have prominent vesicular nuclei with
Fig. 2 Tumour cells are arranged in nests and fascicles separated by
collagenous septa. Nuclei are round to oval, vesicular, with prom-
inent nucleoli. Mitotic figures are numerous. Hematoxylin and eosin
stain ×400
Fig. 1 Diffuse infiltration of the mucosa and submucosa of the
ileum by tumour cells. Hematoxylin and eosin stain ×50
Fig. 3 Strong reactivity of clear cell sarcoma cells for S-100 protein
×400
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mostly a large, central, single nucleolus. Multinucleate
giant tumour cells, a relatively common feature of clear cell
sarcoma of soft tissues, seem to be rarer in the gastroin-
testinal tract (one of seven cases). Intracellular melanin
accumulation is reported in half of the cases.
The tumour cells in clear cell sarcoma of soft tissues usu-
ally express melanocytic makers, including S-100 protein,
Fig. 4 Real-time PCR assay
demonstrating the presence of
EWS–ATF1 transcripts. Graphs
show fluorescence emission data
during each PCR cycle. This
fluorescence is directly related
to the quantity of PCR products.
ATF1, graph of amplification of
EWS–ATF1 transcripts. B2M,
graph of amplification of beta-2-
microglobulin transcripts, used
as internal control
Table 1 Clear cell sarcoma of the gastrointestinal tract
Case Author
(reference)
Age
(years)
Sex Site Size
(cm)
Metastases
at diagnosis
Molecular
confirmation
Treatment Adequacy
of surgical
resection
Outcome
1 Ekfors
et al. [5]
38 M Duodenum 3 No No Truncal vagotomy,
pancreatico-
duodenectomy,
cholecystectomy
Complete AWNED at 18 months
2 Donner
et al. [4]
37 M Ileum 6.5 No Yes
(karyotype)
Intestinal
resection, along
with tumour
Complete Liver mets at 24 and
46 months, AWD
at 46 months
3 Fukuda
et al. [7]
74 M Transverse
colon
2 No Yes
(RT–PCR on
liver met)
Partial colectomy+
regional
lymphadenectomy
Complete Single liver met
at 9 months
(resected), AWD
at 15 months
4 Pauwels
et al. [13]
30 M Stomach 4 Yes (peritoneum,
regional lymph
nodes)
Yes
(karyotype
and FISH)
Palliative partial
gastric resection
Complete Pancreatic, liver and
Douglas cul-de-sac
mets at 4 months,
AWD at 18 months
5 Zambrano
et al. [15]
15 F Jejunum 5 Yes (mesenteric
lymph nodes)
Yes
(karyotype)
Intestinal
resection, along
with tumour
and enlarged
lymph nodes +
CT
Incomplete Tumour progression
at 12 months, DOD
at 16 months
6 Achten
et al. [1]
57 M Jejunum 6.5 No Yes (FISH) Intestinal
resection, along
with tumour
Complete AWNED at 11 months
7 Current
case
35 M Ileum 1.8 No Yes
(RT-PCR)
Intestinal
resection, along
with tumour
Complete Liver mets at 2
months, DOD
at 15 months
DOD Dead of disease, AWD Alive with disease, AWNED Alive with no evidence of disease, mets metastases, CT Chemotherapy, RT–PCR
Reverse transcriptase–polymerase chain reaction, FISH Fluorescence in situ hybridization
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HMB45, melan-A and the melanoma isoform of microph-
thalmia transcription factor (MITF-M) [2]. In the gastroin-
testinal tract, clear cell sarcoma cells consistently expressed
vimentin and S-100 protein. HMB45was expressed in three
of seven cases only, and melan-A in two of four cases with
available data. They were consistently negative for EMA,
cytokeratins, muscle-specific actin, smooth muscle actin,
desmin, CD34, chromogranin, synaptophysin, CD45 and
CD117. Melanosomes at varying stages of development
were visible ultrastructurally in all (6/6) cases with avail-
able data.
The diagnosis of clear cell sarcoma is a challenging one,
especially if the tumour occurs in an unexpected site such
as the gastrointestinal tract. In our case, the diagnosis was
considered only at the time of the peritoneal tumour re-
growth 8 months after the primary tumour had been re-
moved. A metastatic melanoma was initially suspected, but
an extensive work-up failed to find any primary elsewhere.
The other differential diagnoses, successively contemplat-
ed and ruled out on the basis of tumour immunoprofile,
included a poorly-differentiated neuroendocrine carcinoma
(tumour cells were negative for keratins, EMA, chromo-
granin and synaptophysin), a malignant gastrointesti-
nal stromal tumour (negativity for CD117 and CD34), a
clear cell myomelanocytic tumour/PEComa (negativity for
smooth muscle actin, strong positivity for S-100 protein), a
paraganglioma (negativity for chromogranin and synapto-
physin, diffuse positivity for S-100 protein), some sort of
germ cell neoplasia (negativity for epithelial markers and
placental alkaline phosphatase), a synovial sarcoma
(negativity for epithelial markers, absence of detectable
SYT-SSX fusion transcripts), a leiomyosarcoma (negativ-
ity for muscle markers) and a lymphoma (negativity for
lymphoid markers). Although initially considered as im-
probable, the other diagnostic hypotheses that could not be
definitely ruled out included epithelioid malignant pe-
ripheral nerve sheath tumour, sclerosing epithelioid fibro-
sarcoma and clear cell sarcoma. Ruling out the diagnosis
of malignant peripheral nerve sheath tumour was effec-
tively difficult on account of the negativity of the HMB45
marker. Nevertheless, the focal positivity of the melan-A
marker was a helpful indication of the melanocytic differ-
entiation of the tumour. The detection of EWS–ATF1 fu-
sion transcripts by RT-PCR finally demonstrated that this
lesion was a clear cell sarcoma. The lack of primary
tumour elsewhere strongly suggests that this tumour arose
primarily in the ileum and was not a metastatic deposit
from a soft tissue tumour, as has sometimes been reported
[12].
The relationship between clear cell sarcoma and melano-
ma has been controversial for a long time. Both neoplasms
show morphologic features of melanocytic differentiation
(melanin pigment), as well as immunohistochemical and
ultrastructural features (melanosomes), and some authors
refer to clear cell sarcoma as malignant melanoma of soft
parts [3, 5]. Clear cell sarcoma differs, however, from cuta-
neous melanoma in several respects: it is almost always
deep-seated, associated with tendons, tendon sheaths and
aponeuroses, seldom involves the epidermis and behaves
differently, metastasizing predominantly to the lungs. In
addition, clear cell sarcoma bears the t(12;22) (q13;q12)
translocation which is specific for this tumour type and had
never been identified in cutaneous melanoma [2, 8]. This
translocation, present in 75 to 90% of cases, fuses the acti-
vating transcription factor 1 (ATF1) gene on chromosome
12 with the EWS gene on chromosome 22 [2, 8].
Based on these differences, clear cell sarcoma was con-
sidered heretofore as a clinicopathologic entity distinct
from melanoma. However, recent gene expression profil-
ing data would suggest that this is not really the case. While
examining a series of sarcomas including clear cell sar-
comas, Segal et al. [14] found that clear cell sarcomas do
not ‘cluster’ with other soft tissue sarcomas and may rather
represent a distinct genomic subtype of melanoma. In ad-
dition to genes of melanocytic differentiation, this tumour
was also shown to express fibroblast growth factor recep-
tor 1 (FGFR1), a tyrosine kinase receptor involved in
angiogenesis and tumour cell growth and migration, sug-
gesting that the use of tyrosine kinase inhibitors might
have some value in the treatment of patients with un-
controlled disease.
In conclusion, this case shows that clear cell sarcoma of
soft tissues may occur as a primary neoplasm of the gas-
trointestinal tract. It also underlines the pivotal role of mo-
lecular techniques in the diagnostic approach when dealing
with ‘unusual’ locations.
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